ACCESSION: MSBNK-SMB_Measured-HSA001P0190018
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 99
COMMENT: RAW_SPEC {'BLK01_5664': {'bp': 1980658.0, 'sum': 8693148.0}, '13_posi_5833': {'bp': 507332.0, 'sum': 2252574.0}, '13_posi_6004': {'bp': 518674.0, 'sum': 2153987.0}, '15_posi_5939': {'bp': 525014.0, 'sum': 2347046.0}, '14_posi_5878': {'bp': 607689.0, 'sum': 2790892.0}, '5_posi_5834': {'bp': 643479.0, 'sum': 2689841.0}, '14_posi_5980': {'bp': 653674.0, 'sum': 2633537.0}, '9_posi_5709': {'bp': 675439.0, 'sum': 2901074.0}, '4_posi_5651': {'bp': 751282.0, 'sum': 3011034.0}, 'ProcedureBlank_5601': {'bp': 970201.0, 'sum': 3835766.0}, 'BLK02_5033': {'bp': 1044822.0, 'sum': 4428124.0}, 'BLK02_5116': {'bp': 1071523.0, 'sum': 5114651.0}, 'BLK02_5514': {'bp': 1689545.0, 'sum': 5692812.0}, 'BLK01_5748': {'bp': 1952607.0, 'sum': 8543551.0}, '19_posi_5956': {'bp': 476244.0, 'sum': 2026858.0}, '15_posi_5770': {'bp': 534642.0, 'sum': 2298738.0}, '18_posi_5835': {'bp': 571532.0, 'sum': 2300512.0}, '13_posi_5749': {'bp': 576528.0, 'sum': 2276434.0}, '12_posi_5894': {'bp': 668369.0, 'sum': 2891475.0}, '17_posi_5713': {'bp': 669191.0, 'sum': 2417107.0}, '5_posi_5672': {'bp': 680638.0, 'sum': 2836789.0}, '6_posi_5811': {'bp': 687000.0, 'sum': 2877848.0}, '12_posi_6005': {'bp': 692660.0, 'sum': 2791865.0}, '8_posi_6025': {'bp': 840713.0, 'sum': 3138066.0}, 'ProcedureBlank_5687': {'bp': 891677.0, 'sum': 3533162.0}, 'BLK02_5202': {'bp': 1204256.0, 'sum': 5010600.0}, '18_posi_6003': {'bp': 455935.0, 'sum': 2011485.0}, '19_posi_5876': {'bp': 521395.0, 'sum': 2117469.0}, '13_posi_6084': {'bp': 524890.0, 'sum': 2129035.0}, '17_posi_5879': {'bp': 543894.0, 'sum': 2371436.0}, '15_posi_6107': {'bp': 561998.0, 'sum': 2200001.0}, '17_posi_5962': {'bp': 582498.0, 'sum': 2527919.0}, '16_posi_5693': {'bp': 600771.0, 'sum': 2237003.0}, '14_posi_5708': {'bp': 637652.0, 'sum': 2440215.0}, '8_posi_5745': {'bp': 725997.0, 'sum': 3322165.0}, '2_posi_5665': {'bp': 749272.0, 'sum': 3234978.0}, '10_posi_6005': {'bp': 762310.0, 'sum': 2946582.0}, '7_posi_5942': {'bp': 775561.0, 'sum': 2989976.0}, '7_posi_5666': {'bp': 823643.0, 'sum': 3226828.0}, '16_posi_5939': {'bp': 437890.0, 'sum': 2093819.0}, '17_posi_6046': {'bp': 565718.0, 'sum': 2424288.0}, '7_posi_5837': {'bp': 620754.0, 'sum': 2622298.0}, '7_posi_5749': {'bp': 627377.0, 'sum': 2860626.0}, '6_posi_5707': {'bp': 644446.0, 'sum': 2929962.0}, '18_posi_6167': {'bp': 647987.0, 'sum': 2428051.0}, '4_posi_5730': {'bp': 779282.0, 'sum': 3241688.0}, '3_posi_5751': {'bp': 812659.0, 'sum': 3392257.0}, '8_posi_5673': {'bp': 867172.0, 'sum': 3301849.0}, '15_posi_6022': {'bp': 478798.0, 'sum': 2017899.0}, '16_posi_5855': {'bp': 482223.0, 'sum': 2177234.0}, '15_posi_5853': {'bp': 493114.0, 'sum': 2048498.0}, '18_posi_6082': {'bp': 501387.0, 'sum': 2169274.0}, '16_posi_5757': {'bp': 547914.0, 'sum': 2230206.0}, '19_posi_6110': {'bp': 549119.0, 'sum': 2363129.0}, '12_posi_5674': {'bp': 671436.0, 'sum': 2495062.0}, '10_posi_5813': {'bp': 694788.0, 'sum': 3006737.0}, '11_posi_5897': {'bp': 696596.0, 'sum': 2990105.0}, '8_posi_5921': {'bp': 731904.0, 'sum': 2979434.0}, '11_posi_5980': {'bp': 737501.0, 'sum': 2881998.0}, '6_posi_5983': {'bp': 776236.0, 'sum': 2887823.0}, '3_posi_5665': {'bp': 779057.0, 'sum': 3352410.0}, '10_posi_5737': {'bp': 808895.0, 'sum': 3387308.0}, '6_posi_5632': {'bp': 946781.0, 'sum': 3509887.0}, '12_posi_5793': {'bp': 517889.0, 'sum': 2269072.0}, '19_posi_5800': {'bp': 621912.0, 'sum': 2335061.0}, '11_posi_5708': {'bp': 711716.0, 'sum': 2908389.0}, '1_posi_5647': {'bp': 808829.0, 'sum': 3583129.0}, '18_posi_5921': {'bp': 432110.0, 'sum': 1956462.0}, '16_posi_6024': {'bp': 507837.0, 'sum': 2133266.0}, '9_posi_5794': {'bp': 624728.0, 'sum': 2803514.0}, '15_posi_5695': {'bp': 627181.0, 'sum': 2370995.0}, '10_posi_5916': {'bp': 697917.0, 'sum': 2890869.0}, '3_posi_5837': {'bp': 728937.0, 'sum': 3018624.0}, '2_posi_5854': {'bp': 784732.0, 'sum': 3018385.0}, '5_posi_5920': {'bp': 787559.0, 'sum': 3087357.0}, '10_posi_5665': {'bp': 854426.0, 'sum': 3227658.0}, 'BLK02_5688': {'bp': 1061010.0, 'sum': 4124736.0}, 'BLK02_5369': {'bp': 1539662.0, 'sum': 5450663.0}, '13_posi_5917': {'bp': 509948.0, 'sum': 2351009.0}, '11_posi_5813': {'bp': 659361.0, 'sum': 2872214.0}, '8_posi_5835': {'bp': 679533.0, 'sum': 2920674.0}, '19_posi_6194': {'bp': 645330.0, 'sum': 2476735.0}, '2_posi_5751': {'bp': 758652.0, 'sum': 3127874.0}, '16_posi_6109': {'bp': 585375.0, 'sum': 2361069.0}, '17_posi_6129': {'bp': 671705.0, 'sum': 2567706.0}, 'BLK02_4949': {'bp': 1070896.0, 'sum': 4063958.0}, '4_posi_5897': {'bp': 804539.0, 'sum': 3192089.0}, '9_posi_5962': {'bp': 674356.0, 'sum': 2766800.0}, '17_posi_5792': {'bp': 546024.0, 'sum': 2284708.0}, 'ProcedureBlank_4993': {'bp': 933061.0, 'sum': 3886935.0}, '18_posi_5758': {'bp': 648216.0, 'sum': 2381411.0}, '19_posi_6037': {'bp': 464922.0, 'sum': 2117089.0}, '4_posi_5811': {'bp': 720795.0, 'sum': 3001781.0}, '6_posi_5896': {'bp': 658215.0, 'sum': 2689890.0}, '9_posi_5876': {'bp': 621218.0, 'sum': 2747402.0}, '1_posi_5749': {'bp': 887189.0, 'sum': 3386588.0}, '14_posi_5793': {'bp': 770642.0, 'sum': 3207969.0}, '5_posi_5749': {'bp': 712191.0, 'sum': 3122101.0}, 'BLK02_5287': {'bp': 1345190.0, 'sum': 5066279.0}}
COMMENT: RETENTION_TIME_STDEV 0.468
COMMENT: PRECURSOR_M/Z_RAW 190.107056
COMMENT: PRECURSOR_M/Z_STDEV 0.000047
COMMENT: PRECURSOR_IN_MS1 mz 190.107362; int 192.232; delta(ppm) 0.938897
COMMENT: PROPOSED_CHARGE_STATE +1; mz 191.110623; int 15.382; cor 0.933
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+NH4; mz 175.107683; int 9.964; cor 0.703
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.137; C8H15NO4; [M+H]+; delta(ppm) -0.137493
COMMENT: PROPOSED_MF SevenGoldenRules 0.153; C7H11NO3; [M+CH3OH+H]+; delta(ppm) -0.152794
COMMENT: PROPOSED_MF MS-FINDER 3.407; C8H15NO4; [M+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_MF MS-FINDER 3.405; C7H11NO3; [M+CH3OH+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_MF SIRIUS5_Sirius 59.270; C8H15NO4; [M+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_MF SIRIUS5_Sirius 53.174; C7H11NO3; [M+CH4O+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.335; C9H11N5; [M+H]+; delta(ppm) -7.173894
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H15NO4; [M+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H11NO3; [M+CH4O+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_MF SIRIUS6_Sirius 78.072; C5H9N4O2; [M+CH4O+H]+; delta(ppm) 6.923808
COMMENT: PROPOSED_MF SIRIUS6_Sirius 78.072; C6H13N4O3; [M+H]+; delta(ppm) 6.923808
COMMENT: PROPOSED_MF SIRIUS6_Sirius 75.012; C7H11NO3; [M+CH4O+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_MF SIRIUS6_Sirius 75.012; C8H15NO4; [M+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_MF SIRIUS6_Sirius 62.858; C5H11BN2OS; [M+CH4O+H]+; delta(ppm) 55608.349597
COMMENT: PROPOSED_MF SIRIUS6_Sirius 62.858; C6H15BN2O2S; [M+H]+; delta(ppm) 55608.349597
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.842; C6H15NSi2; [M+CH4O+H]+; delta(ppm) -251698.849467
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.842; C7H19NOSi2; [M+H]+; delta(ppm) -251698.849467
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.137; C7H12FNSi; [M+CH4O+H]+; delta(ppm) -251692.958208
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.137; C8H16FNOSi; [M+H]+; delta(ppm) -251692.958208
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.474; C9H11N5; [M+H]+; delta(ppm) -7.173894
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.727; C5H14N6P; [M+H]+; delta(ppm) -8.799808
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.256; C8H19NSSi; [M+H]+; delta(ppm) -251699.522146
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H11NO3; [M+CH4O+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H15NO4; [M+H]+; delta(ppm) -0.138899
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.739; JDVVGAQPNNXQDW-HFCBTUDCNA-N; [M+H]+; O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.724; AIQMLBKBQCVDEY-JUPQXLBLNA-N; [M+H]+; OC[C@@H]1[C@@H](O)[C@H](O)[C@@H]2[C@@H](O)CCN12
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.702; WXELLRXNGRTSJY-IMHHCQLZNA-N; [M+H]+; O[C@@H]1CN2(=O)CCC[C@@H](O)[C@@H]2[C@@H]1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.697; GMLTZNHZYSKWCB-UHFFFAOYSA-N; [M+H]+; O=C(OC)C1N(C)CC(O)C(O)C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.656; GZDWTPRPLBRISA-UHFFFAOYNA-N; [M+H]+; CN1C2CCC1(O)C(O)C(O)C2O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.676; JDVVGAQPNNXQDW-HFCBTUDCNA-N; [M+H]+; Castanospermine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.589; VQASKUSHBVDKGU-UHFFFAOYSA-N; [M+CH3OH+H]+; Paramethadione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.563; PFWQSHXPNKRLIV-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-Methylcrotonylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.562; GZDWTPRPLBRISA-UHFFFAOYNA-N; [M+H]+; N-Methylcalystegine B2
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.553; AIQMLBKBQCVDEY-JUPQXLBLNA-N; [M+H]+; Alexine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.538; CHRXIJXXDQWKCQ-UHFFFAOYSA-N; [M+H]+; 2-[(4-hydroxy-4-methyloxan-3-yl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.530; GMLTZNHZYSKWCB-UHFFFAOYSA-N; [M+H]+; methyl 4,5-dihydroxy-1-methylpiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.522; UEGDICIJUUEIOL-FSPLSTOPSA-N; [M+CH3OH+H]+; 2-Hydroxyethylclavam
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.496; IJKKTQLUXOILBQ-DMLYIKQDNA-N; [M+H]+; N-lactoyl-Valine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.491; WRUSVQOKJIDBLP-HWKANZROSA-N; [M+CH3OH+H]+; Tiglylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.490; JDVRHBSRVFYFOR-MDOHGIEYNA-N; [M+H]+; UNPD951
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.465; FWULQXYJOANGSS-UHFFFAOYNA-N; [M+H]+; 2 -(Butylamido)-4-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.462; MXWMFBYWXMXRPD-RXMQYKEDSA-N; [M+H]+; (2R)-2-amino-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.455; SPEWJLQOEIFOJI-FXATWUBVNA-N; [M+H]+; UNPD70010
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.455; YQMRIHFIEQHCOJ-UHFFFAOYNA-N; [M+H]+; 2-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.453; ZTLDTRZYHPXXPS-MZQZIECVNA-N; [M+H]+; UNPD160442
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.442; GNMSLDIYJOSUSW-LURJTMIESA-N; [M+CH3OH+H]+; N-Acetylproline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.434; WXELLRXNGRTSJY-IMHHCQLZNA-N; [M+H]+; Swainsonine N-oxide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.432; AYNJYFWPCLXDNL-UHFFFAOYNA-N; [M+H]+; 3-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.432; MRWDIRTUXFYBHJ-UHFFFAOYNA-N; [M+H]+; 4-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.432; YAFMZZZZHXVTEJ-UHFFFAOYNA-N; [M+H]+; 5-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.431; MBBNCIKYWHIZGN-UHFFFAOYNA-N; [M+H]+; 1-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.429; GGSYOGJSNRQKCY-UHFFFAOYSA-N; [M+H]+; 3-(acetyloxy)-3-(trimethylazaniumyl)propanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.427; PLPHCVHEYFTFOF-DKAGPWHGNA-N; [M+H]+; UNPD21951
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.425; WDMSIBWBBAAFED-GZEUMZHQNA-N; [M+H]+; UNPD194395
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.423; NOSUUIPGNMAALM-ZETCQYMHSA-N; [M+H]+; (2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.421; YRXIMPFOTQVOHG-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl](methyl)amino}acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.420; WCFJUSRQHZPVKY-UHFFFAOYSA-N; [M+H]+; 3-{[(tert-butoxy)carbonyl]amino}propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.419; LFMOJNDZFCHHPV-JLDDOWRYNA-N; [M+H]+; 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.415; PKTVOVWATFEUOE-UHFFFAOYSA-N; [M+H]+; 2-[[bis(2-hydroxyethyl)amino]methyl]prop-2-enoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.399; BPNNJABAUGSBLB-UHFFFAOYSA-N; [M+H]+; beta-valienamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.390; QVHJQCGUWFKTSE-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl]amino}propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.380; QLTOPDVYGNULFB-UHFFFAOYSA-N; [M+H]+; 4-methylmorpholin-2-yl 2-methoxyacetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.343; LZHSHKSQRPIMMV-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 3-acetamidobut-2-enoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.336; YVDHZNIQWHUORH-WZTWBHKBNA-N; [M+H]+; 3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.329; PNOKUGWGMLEAPE-LMPMJJBRNA-N; [M+CH3OH+H]+; furanomycin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.328; ABAOXDQXQHQRFA-YFKPBYRVSA-N; [M+CH3OH+H]+; methyl 1-methyl-5-oxo-L-prolinate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.325; FXIQOWGSQOLZSR-UHFFFAOYSA-N; [M+CH3OH+H]+; N,N-dimethyl-5-oxooxolane-2-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.325; UKQLYCSMIVXPDB-MLHKIVSYNA-N; [M+CH3OH+H]+; UNPD93618
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.314; ABNUGWRZSYVEEW-APVHJGEINA-N; [M+CH3OH+H]+; UNPD20878
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.314; VBBWEKADEDMWDH-UHFFFAOYSA-N; [M+CH3OH+H]+; CNP0446389
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.305; QYJOOVQLTTVTJY-MLHKIVSYNA-N; [M+CH3OH+H]+; UNPD56624
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.296; PEAQTUDKZGSVCV-DWFKHXNSNA-N; [M+CH3OH+H]+; UNPD165417
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.273; VSVIYBLRPXAQBF-SNAWJCMRSA-N; [M+CH3OH+H]+; UNPD149056
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.270; PDEQNWFUJRROAD-IFSCUNPJNA-N; [M+CH3OH+H]+; UNPD109941
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.253; ZESDLVJGIBGADW-MZQZIECVNA-N; [M+CH3OH+H]+; UNPD146866
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.246; CSBJIXVKDCZBPF-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(5-oxopyrrolidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.245; VLIHXBQWXDIQTE-MZQZIECVNA-N; [M+CH3OH+H]+; UNPD140628
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.231; HPDZYDTXCOFUOY-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-oxopyrrolidin-1-acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.218; FQOWJGGXNSRNJS-YFKPBYRVSA-N; [M+CH3OH+H]+; (2S)-2-(2-methylprop-2-enoylamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.199; MGICTTHNDAIMFI-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-(but-3-enamido)acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.183; SIGSNYAYBSJATD-UHFFFAOYSA-N; [M+CH3OH+H]+; Ethadione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.150; CESXXYZXSIXCFU-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-amino-4-oxocyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.121; VQYNVVZGKXZWFV-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-imino-5-methyl-3-oxohexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.107; XFMMSQQRBYPHPZ-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-acetyl-3-iminobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WCFJUSRQHZPVKY-UHFFFAOYSA-N; [M+H]+; 3-{[(tert-butoxy)carbonyl]amino}propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CSBJIXVKDCZBPF-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(5-oxopyrrolidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; JDVRHBSRVFYFOR-MDOHGIEYNA-N; [M+H]+; UNPD951
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.977; ZTLDTRZYHPXXPS-MZQZIECVNA-N; [M+H]+; UNPD160442
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.959; QVHJQCGUWFKTSE-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl]amino}propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.917; MGICTTHNDAIMFI-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-(but-3-enamido)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.881; VSVIYBLRPXAQBF-SNAWJCMRSA-N; [M+CH3OH+H]+; UNPD149056
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.848; YAFMZZZZHXVTEJ-UHFFFAOYNA-N; [M+H]+; 5-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.839; FQOWJGGXNSRNJS-YFKPBYRVSA-N; [M+CH3OH+H]+; (2S)-2-(2-methylprop-2-enoylamino)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.838; GMLTZNHZYSKWCB-UHFFFAOYSA-N; [M+H]+; methyl 4,5-dihydroxy-1-methylpiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.830; CHRXIJXXDQWKCQ-UHFFFAOYSA-N; [M+H]+; 2-[(4-hydroxy-4-methyloxan-3-yl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.825; WRUSVQOKJIDBLP-HWKANZROSA-N; [M+CH3OH+H]+; Tiglylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.814; HPDZYDTXCOFUOY-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-oxopyrrolidin-1-acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.814; LZHSHKSQRPIMMV-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 3-acetamidobut-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.814; PFWQSHXPNKRLIV-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-Methylcrotonylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.810; JDVVGAQPNNXQDW-HFCBTUDCNA-N; [M+H]+; Castanospermine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.809; IJKKTQLUXOILBQ-DMLYIKQDNA-N; [M+H]+; N-lactoyl-Valine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.808; FWULQXYJOANGSS-UHFFFAOYNA-N; [M+H]+; 2 -(Butylamido)-4-hydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.801; AIQMLBKBQCVDEY-JUPQXLBLNA-N; [M+H]+; Alexine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.800; QLTOPDVYGNULFB-UHFFFAOYSA-N; [M+H]+; 4-methylmorpholin-2-yl 2-methoxyacetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.794; QYJOOVQLTTVTJY-MLHKIVSYNA-N; [M+CH3OH+H]+; UNPD56624
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.786; WDMSIBWBBAAFED-GZEUMZHQNA-N; [M+H]+; UNPD194395
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.786; WXELLRXNGRTSJY-IMHHCQLZNA-N; [M+H]+; Swainsonine N-oxide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.765; MRWDIRTUXFYBHJ-UHFFFAOYNA-N; [M+H]+; 4-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.753; SPEWJLQOEIFOJI-FXATWUBVNA-N; [M+H]+; UNPD70010
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.751; YRXIMPFOTQVOHG-UHFFFAOYSA-N; [M+H]+; 2-{[(tert-butoxy)carbonyl](methyl)amino}acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.750; AYNJYFWPCLXDNL-UHFFFAOYNA-N; [M+H]+; 3-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.750; MBBNCIKYWHIZGN-UHFFFAOYNA-N; [M+H]+; 1-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.750; YQMRIHFIEQHCOJ-UHFFFAOYNA-N; [M+H]+; 2-hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.741; PKTVOVWATFEUOE-UHFFFAOYSA-N; [M+H]+; 2-[[bis(2-hydroxyethyl)amino]methyl]prop-2-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.740; BPNNJABAUGSBLB-UHFFFAOYSA-N; [M+H]+; beta-valienamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.734; GZDWTPRPLBRISA-UHFFFAOYNA-N; [M+H]+; N-Methylcalystegine B2
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.734; PLPHCVHEYFTFOF-DKAGPWHGNA-N; [M+H]+; UNPD21951
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.728; UKQLYCSMIVXPDB-MLHKIVSYNA-N; [M+CH3OH+H]+; UNPD93618
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.726; NOSUUIPGNMAALM-ZETCQYMHSA-N; [M+H]+; (2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.717; UEGDICIJUUEIOL-FSPLSTOPSA-N; [M+CH3OH+H]+; 2-Hydroxyethylclavam
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.711; ABAOXDQXQHQRFA-YFKPBYRVSA-N; [M+CH3OH+H]+; methyl 1-methyl-5-oxo-L-prolinate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.707; PDEQNWFUJRROAD-IFSCUNPJNA-N; [M+CH3OH+H]+; UNPD109941
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.703; CESXXYZXSIXCFU-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-amino-4-oxocyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.688; GGSYOGJSNRQKCY-UHFFFAOYSA-N; [M+H]+; 3-(acetyloxy)-3-(trimethylazaniumyl)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.684; XFMMSQQRBYPHPZ-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-acetyl-3-iminobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.673; GNMSLDIYJOSUSW-LURJTMIESA-N; [M+CH3OH+H]+; N-Acetylproline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.659; VLIHXBQWXDIQTE-MZQZIECVNA-N; [M+CH3OH+H]+; UNPD140628
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.659; ZESDLVJGIBGADW-MZQZIECVNA-N; [M+CH3OH+H]+; UNPD146866
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.658; PNOKUGWGMLEAPE-LMPMJJBRNA-N; [M+CH3OH+H]+; furanomycin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.651; ABNUGWRZSYVEEW-APVHJGEINA-N; [M+CH3OH+H]+; UNPD20878
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.612; PEAQTUDKZGSVCV-DWFKHXNSNA-N; [M+CH3OH+H]+; UNPD165417
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.607; VBBWEKADEDMWDH-UHFFFAOYSA-N; [M+CH3OH+H]+; CNP0446389
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.594; FXIQOWGSQOLZSR-UHFFFAOYSA-N; [M+CH3OH+H]+; N,N-dimethyl-5-oxooxolane-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.528; SIGSNYAYBSJATD-UHFFFAOYSA-N; [M+CH3OH+H]+; Ethadione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.523; VQASKUSHBVDKGU-UHFFFAOYSA-N; [M+CH3OH+H]+; Paramethadione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.332; LFMOJNDZFCHHPV-JLDDOWRYNA-N; [M+H]+; 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.312; VQYNVVZGKXZWFV-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-imino-5-methyl-3-oxohexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.282; MXWMFBYWXMXRPD-RXMQYKEDSA-N; [M+H]+; (2R)-2-amino-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.226; YVDHZNIQWHUORH-WZTWBHKBNA-N; [M+H]+; 3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.791; JDVVGAQPNNXQDW-TVNFTVLESA-N; [M+H]+; (1S,6S,7R,8R,8aR)-1,2,3,5,6,7,8,8a-octahydroindolizine-1,6,7,8-tetrol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.048; VQASKUSHBVDKGU-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-ethyl-3,5-dimethyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.612; GNMSLDIYJOSUSW-LURJTMIESA-N; [M+CH3OH+H]+; (2S)-1-acetylpyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.447; PFWQSHXPNKRLIV-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(3-methylbut-2-enoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.386; QVHJQCGUWFKTSE-YFKPBYRVSA-N; [M+H]+; (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.105; WRUSVQOKJIDBLP-HWKANZROSA-N; [M+CH3OH+H]+; 2-[[(E)-2-methylbut-2-enoyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.075; SIGSNYAYBSJATD-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-ethyl-5,5-dimethyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.565; WCFJUSRQHZPVKY-UHFFFAOYSA-N; [M+H]+; 3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.447; YRXIMPFOTQVOHG-UHFFFAOYSA-N; [M+H]+; 2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.427; ZCQGVFNHUATAJY-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-[methyl(prop-2-enoyl)amino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.401; QYJOOVQLTTVTJY-YFKPBYRVSA-N; [M+CH3OH+H]+; ethyl (2S)-5-oxopyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.341; LJDNMOCAQVXVKY-UHFFFAOYSA-N; [M+H]+; ethyl 2-[(2-ethoxy-2-oxoethyl)amino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.258; PHUZOEOLWIHIKH-UHFFFAOYSA-N; [M+H]+; methyl 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.251; ONLCLPRCWSOGPM-UHFFFAOYSA-N; [M+H]+; 2-(3-methyl-3-nitrobutyl)-1,3-dioxolane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.233; YOFPFYYTUIARDI-LURJTMIESA-N; [M+H]+; (2S)-2-aminooctanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.232; CSBJIXVKDCZBPF-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(5-oxopyrrolidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.224; MQXIMPGNIJCBHZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-oxoazepane-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.219; BOMJMFPCSAPKAO-UHFFFAOYSA-N; [M+H]+; ethyl 2-nitrohexanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.205; AMDDRMIFTJHJGD-RITPCOANSA-N; [M+H]+; (2S)-2-[[(1R)-1-carboxyethyl]amino]pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.203; MHWYRGPPKCKIQY-UHFFFAOYSA-N; [M+H]+; 2-(1-carboxyethylamino)-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.182; RQULWPSGQYZREI-LURJTMIESA-N; [M+H]+; (2S)-2-amino-5-(1,3-dioxolan-2-yl)pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.161; AXRVAYHUTGGQHA-UHFFFAOYSA-N; [M+H]+; ethyl 4,5-dihydroxypiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.160; YRXLABUVDQYDHV-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-(prop-2-enoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.133; JYGXQTZBIRNFBN-UHFFFAOYSA-N; [M+H]+; 2-(2-acetyloxyethylamino)ethyl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.131; XOMYTIUVNSWEAI-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(2-oxopyrrolidin-1-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; JFZRRXGXEHUJCI-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 1-methyl-5-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; AIQMLBKBQCVDEY-OZRXBMAMSA-N; [M+H]+; (1R,2R,3R,7S,8R)-3-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizine-1,2,7-triol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.083; BKGPMRISIFTLAH-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-[methyl(prop-2-enoyl)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; JLIAUXQHFQGOGT-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(5-oxopyrrolidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; HMNXRLQSCJJMBT-LURJTMIESA-N; [M+H]+; diethyl (2S)-2-aminobutanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.060; CHRXIJXXDQWKCQ-XPUUQOCRSA-N; [M+H]+; 2-[[(3S,4S)-4-hydroxy-4-methyloxan-3-yl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; KDUIBZJVAXYHPY-ONEGZZNKSA-N; [M+CH3OH+H]+; (E)-4-oxo-4-(propylamino)but-2-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.058; LWKNKHVVZLDUEM-UHFFFAOYSA-N; [M+H]+; 4-nitrohexan-3-yl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; PVQNBPIHNVOKIE-UCROKIRRSA-N; [M+H]+; methyl (1R,2S,4S,5R)-2-amino-4,5-dihydroxycyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.044; GABNCVVJUQVULK-IHBLQFBFSA-N; [M+H]+; 1-[(2S,3R,4S,5R)-3,4,5-trihydroxy-2-methylpiperidin-1-yl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.042; VSQPEDPYPBOLOK-ZCFIWIBFSA-N; [M+H]+; tert-butyl (4R)-4-hydroxy-1,2-oxazolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.039; IJKKTQLUXOILBQ-WDSKDSINSA-N; [M+H]+; (2S)-2-[[(2S)-2-hydroxypropanoyl]amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.026; LOQFROBMBSKWQY-ZCFIWIBFSA-N; [M+CH3OH+H]+; ethyl (3R)-4-cyano-3-hydroxybutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; HPDZYDTXCOFUOY-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-(2-oxopyrrolidin-1-yl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; SLOUPZPBSMXCPG-UHFFFAOYSA-N; [M+H]+; diethyl 2-(methylamino)propanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; LWZZSGQZDKTWPR-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-(hydroxymethyl)oxazetidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.009; IPROINJJJLRTQV-UHFFFAOYSA-N; [M+H]+; diethyl 2-amino-2-methylpropanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.989; HPDQADRQTVTWTP-ARJAWSKDSA-N; [M+CH3OH+H]+; (Z)-4-oxo-4-(propan-2-ylamino)but-2-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; QSEXRJPSOUALOF-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-[cyclopropanecarbonyl(methyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.979; LKYYGCNRZKZWLZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-oxopiperidin-1-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.976; NQAYDNHKIKCYNL-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-[ethyl(prop-2-enoyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.976; QJYQNYXPOPJYSU-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-oxopiperidin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; QSTXMZUAMCBUQU-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methyl-5-oxopyrrolidin-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; PUWCNJZIFKBDJQ-YFKPBYRVSA-N; [M+H]+; (3S)-3-amino-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; GIFZQJHZLDAKOK-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methyl-5-oxopyrrolidin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; BZOZZHITPNLXLM-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-ethyl-2-oxopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; BSWMFLPHDUMFNS-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-methyl-2-oxopyrrolidin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.970; FHHMWJMUMOYGQW-UHFFFAOYSA-N; [M+CH3OH+H]+; ethyl 2-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; PNOKUGWGMLEAPE-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-amino-2-(5-methyl-2,5-dihydrofuran-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.968; GQAFTUMTSHDPRD-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(6-oxopiperidin-2-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.967; WWBAHELRZNIKDI-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(6-oxopiperidin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.967; GZDWTPRPLBRISA-UHFFFAOYSA-N; [M+H]+; 8-methyl-8-azabicyclo[3.2.1]octane-1,2,3,4-tetrol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; BNPUQHZYYWBHSW-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-ethyl-5-oxopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.960; RJGVYIKJSMBGDK-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(3-ethyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.955; LGABVVFSYBSLDO-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 3-methyl-2-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.954; SBYCWQPNKUMQSR-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(1-acetamidocyclopropyl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; LVKROKMNCYTCHK-WDSKDSINSA-N; [M+H]+; (2S,3S)-2-(methoxycarbonylamino)-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; RZODYIKYXCEAFJ-FSDSQADBSA-N; [M+H]+; methyl (2R,3S,4R)-3,4-dimethoxypyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; AJTPFZSLRYHOCT-UHFFFAOYSA-N; [M+CH3OH+H]+; ethyl 2-acetamidoprop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.938; XBNGBGYWMXBQRX-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 4-oxopiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; PKCIDMQPMJHMGR-UHFFFAOYSA-N; [M+CH3OH+H]+; 7-oxoazepane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; ABAOXDQXQHQRFA-YFKPBYRVSA-N; [M+CH3OH+H]+; methyl (2S)-1-methyl-5-oxopyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.920; AGWPBFFUIGQGJG-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-ethyl-5-oxopyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.914; IZNTWTMLHCGAJU-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-formylpiperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; OZWUPGBEUVJVEN-RFZPGFLSSA-N; [M+CH3OH+H]+; (2R,4R)-4-methyl-6-oxopiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; ROSIVTQTEZPZLA-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-ethyl-5-methyl-1,3-oxazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; ZHFYGKPIJJBFJH-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-methyl-2-oxopiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; DQYGBMLEVQLDQC-UHFFFAOYSA-N; [M+CH3OH+H]+; ethyl 3-oxopyrrolidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; ZPCFPPPPCGXLQV-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-methyl-6-oxopiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; FMJFVLZWISHVOE-UHFFFAOYSA-N; [M+CH3OH+H]+; 2,2-dimethyl-5-oxopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.899; LANUZOBKRIJYEJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 5,5-diethyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; BIESXMIFDWYKTQ-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-oxopiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; FQRTVGXATBBMPJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-methyl-2-oxopiperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; NWPRXAIYBULIEI-RXMQYKEDSA-N; [M+H]+; (2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.894; OBFVZDIXAGVZLZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 7-oxoazepane-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; FMLCUICPLLRLEU-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-methyl-6-oxopiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.886; GVDRIEURYWMQNO-UHFFFAOYSA-N; [M+CH3OH+H]+; ethyl 4-isocyanatobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.884; UKQLYCSMIVXPDB-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 6-oxopiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.884; YORUFIOEZHJAEZ-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 6-oxopiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.884; GTXXDFUYEKXHRF-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-methyl-6-oxopiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.882; VAWAHMBIMWIMAA-UHFFFAOYSA-N; [M+CH3OH+H]+; 1,3-dimethyl-5-oxopyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.879; JCVZXXSBCISMLJ-LURJTMIESA-N; [M+CH3OH+H]+; methyl (2S)-2-isocyanato-3-methylbutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; NPRGOLCTGVFFGS-UHFFFAOYSA-N; [M+H]+; 2-(methoxycarbonylamino)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; XPYJCKBYZDSVTK-SNAWJCMRSA-N; [M+CH3OH+H]+; methyl (E)-4-(dimethylamino)-2-oxobut-3-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.864; NAEVKGHXFVBGHJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 3-(2-hydroxyethyl)-3-methylpyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.861; KZMBWDGCFLVNTQ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(3-hydroxypropyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; RXWUZUGCBFZCCG-UHFFFAOYSA-N; [M+H]+; 5-(diethoxymethyl)-1,3-oxazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; QTNLDKHXFVSKCF-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-acetamidopent-4-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.846; YAQRPUZOGYLKNZ-UHFFFAOYSA-N; [M+CH3OH+H]+; ethyl 3-isocyanatobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.844; QXAZQNAFKUKXOL-UHFFFAOYSA-N; [M+CH3OH+H]+; ethyl 4-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; FEQQMBBBBFVNMN-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-acetylpyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.834; LZBWETNXIZOALQ-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 5-methoxy-3,4-dihydro-2H-pyrrole-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.827; QZCFAUQFXXRHIT-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 2-(2-oxopropylamino)prop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.825; UHRUAPNWENGYTC-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-nitrocycloheptan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.824; JGERSIMTYFKSKH-UHFFFAOYSA-N; [M+CH3OH+H]+; methyl 5-methoxy-3,4-dihydro-2H-pyrrole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.822; AAMWBMZCAOJKJU-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-methyl-2-oxopiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -86.912; GNMSLDIYJOSUSW; [M+CH4O+H]+; Acetylproline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -107.929; XOMYTIUVNSWEAI; [M+CH4O+H]+; 2-Oxo-1-pyrrolidinepropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -110.106; XBNGBGYWMXBQRX; [M+CH4O+H]+; 3-Carbomethoxy-4-Piperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -110.737; FEQQMBBBBFVNMN; [M+CH4O+H]+; 1-acetylpyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -116.865; HPDZYDTXCOFUOY; [M+CH4O+H]+; Methyl 2-oxopyrrolidin-1-acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.491; LKYYGCNRZKZWLZ; [M+CH4O+H]+; 2-(2-oxopyridin-1-yl)acetate;
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -123.862; JDVVGAQPNNXQDW; [M+H]+; Tocris-0759
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -126.046; AIQMLBKBQCVDEY; [M+H]+; Alexine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -137.052; FMLCUICPLLRLEU; [M+CH4O+H]+; 1-methyl-6-oxopiperidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -137.361; CSBJIXVKDCZBPF; [M+CH4O+H]+; 3-(5-oxopyrrolidin-2-yl)propanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.915; IZNTWTMLHCGAJU; [M+CH4O+H]+; 1-Formylisonipecotic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -143.450; JYGXQTZBIRNFBN; [M+H]+; 2,2''-Iminobisethyl diacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -145.551; QSTXMZUAMCBUQU; [M+CH4O+H]+; 2-Pyrrolidineacetic acid, 1-methyl-5-oxo-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.783; WXELLRXNGRTSJY; [M+H]+; Swainsonine N-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -157.768; MBBNCIKYWHIZGN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.814; UKQLYCSMIVXPDB; [M+CH4O+H]+; Methyl 6-oxopiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -159.381; LJDNMOCAQVXVKY; [M+H]+; zlchem 799
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -160.034; ABAOXDQXQHQRFA; [M+CH4O+H]+; methyl-1-methyl-5-oxoprolinat
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.219; HWBCQIAPJGSVJG; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.025; AMDDRMIFTJHJGD; [M+H]+; N-[(1R)-1-carboxyethyl]-L-norvaline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.376; YRXLABUVDQYDHV; [M+CH4O+H]+; 4-(prop-2-enoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.643; QYJOOVQLTTVTJY; [M+CH4O+H]+; Ethyl pyroglutamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.649; VSVIYBLRPXAQBF; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.135; HMNXRLQSCJJMBT; [M+H]+; Diethyl aspartate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.807; VAWAHMBIMWIMAA; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.226; PKCIDMQPMJHMGR; [M+CH4O+H]+; 7-oxoazepane-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.980; FHHMWJMUMOYGQW; [M+CH4O+H]+; ethyl 2-oxopyrrolidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.798; JFZRRXGXEHUJCI; [M+CH4O+H]+; 1-Methyl-4-methyloxycarbonyl-2-pyrrolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.990; YOFPFYYTUIARDI; [M+H]+; 2-Aminosuberate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.198; GVDRIEURYWMQNO; [M+CH4O+H]+; ACMC-20akye
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.419; XYYFQOQNHIZVBG; [M+CH4O+H]+; (cyclopentylcarbamoyl)formic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -196.105; CESXXYZXSIXCFU; [M+CH4O+H]+; AmbotzHAA1603
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.495; UMCLCZMPTREESK; [M+CH4O+H]+; 2-Ethoxyethyl cyanoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.146; LOQFROBMBSKWQY; [M+CH4O+H]+; ethyl 4-cyano-3-hydroxybutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.017; KDUIBZJVAXYHPY; [M+CH4O+H]+; N-n-Propylmaleamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.503; XFMMSQQRBYPHPZ; [M+CH4O+H]+; methyl 2-acetyl-3-iminobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.808; HOEOMWYFJBSYSF; [M+CH4O+H]+; Methyl4-oxopiperidine-1-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.526; MGICTTHNDAIMFI; [M+CH4O+H]+; Glycine,N-(1-oxo-3-buten-1-yl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.867; JDVRHBSRVFYFOR; [M+H]+; 2-amino-7-methoxy-7-oxoheptanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.548; DQYGBMLEVQLDQC; [M+CH4O+H]+; 1-Ethoxycarbonyl-3-pyrrolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.805; BOMJMFPCSAPKAO; [M+H]+; ethyl 2-nitrohexanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.385; LYNLJRWPCQRLBT; [M+CH4O+H]+; 1-carbamoylcyclopentane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.936; RMZSOGJUEUFCBK; [M+CH4O+H]+; Butyl isocyanatoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.163; QTNLDKHXFVSKCF; [M+CH4O+H]+; AmbotzAAA1953
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -227.710; PFWQSHXPNKRLIV; [M+CH4O+H]+; 3-Methylcrotonylglycin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -230.409; GFYZJCBOJANRTM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.856; KTFIIPGBMUUNEO; [M+H]+; N-[4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.985; JPGTZLMGEUIJGV; [M+CH4O+H]+; ACMC-20mhoh
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -234.308; RQULWPSGQYZREI; [M+H]+; ACMC-20akoj
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.351; WRUSVQOKJIDBLP; [M+CH4O+H]+; Tiglylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.840; ZTLDTRZYHPXXPS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.500; FWULQXYJOANGSS; [M+H]+; N-(butyryl)homoserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.018; LZHSHKSQRPIMMV; [M+CH4O+H]+; methyl 3-acetamidobut-2-enoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.175; WWFGWBHKRFILGQ; [M+CH4O+H]+; (E)-3-[(4-hydroxy-2-oxobutyl)amino]prop-2-enal
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.373; FXITUJNZFYVSNC; [M+CH4O+H]+; 3-hydroxy-4-(3-oxoprop-1-enylamino)butanal
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.875; UEGDICIJUUEIOL; [M+CH4O+H]+; Hydroxyethylclavam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -247.313; SPEWJLQOEIFOJI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.246; CHRXIJXXDQWKCQ; [M+H]+; 2-[(4-hydroxy-4-methyloxan-3-yl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.780; NOSUUIPGNMAALM; [M+H]+; (2R)-2-[[formyl(hydroxy)amino]methyl]hexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.874; MXWMFBYWXMXRPD; [M+H]+; AmbotzHAA1072
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.729; KSHPPVDRUPZGTP; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -255.258; ROSIVTQTEZPZLA; [M+CH4O+H]+; 5-ethyl-5-methyl-1,3-oxazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.171; LFMOJNDZFCHHPV; [M+H]+; 2-[[formyl(hydroxy)amino]methyl]-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.565; LWKNKHVVZLDUEM; [M+H]+; 4-nitrohexan-3-yl Acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.404; ARUQUOQAOGPTLW; [M+H]+; tert-butyl 2-methyl-2-nitropropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.315; ZESDLVJGIBGADW; [M+CH4O+H]+; 2-Amino-4-hydroxy-6-heptynoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.666; AYNJYFWPCLXDNL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -262.114; YAFMZZZZHXVTEJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.311; PUGDEACANJGZAI; [M+CH4O+H]+; 1-(Dimethylcarbamoyl)cyclopropanecarboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.823; WXYQMZWCFSAKTA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.876; XPFZSQWNBYCQMP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.255; SIGSNYAYBSJATD; [M+CH4O+H]+; Dimedion
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.914; VLIHXBQWXDIQTE; [M+CH4O+H]+; 2-Amino-4-hydroxymethyl-5-hexynoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.748; GZDWTPRPLBRISA; [M+H]+; N-Methylcalystegine B2
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.255; HPDQADRQTVTWTP; [M+CH4O+H]+; Maleamic acid, N-isopropyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -277.630; JCVZXXSBCISMLJ; [M+CH4O+H]+; methyl N-(oxomethylene)valinate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.145; WDMSIBWBBAAFED; [M+H]+; N-(3,6-dihydroxy-2-methyloxan-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.159; MRWDIRTUXFYBHJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -281.723; NBYRCTHMAXYMJN; [M+CH4O+H]+; 4-(dimethylaminomethyl)oxolane-2,3-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.803; GGSYOGJSNRQKCY; [M+H]+; Spectrum_001493
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.871; PBVFADSFYQFKNL; [M+CH4O+H]+; Methylcarbamylethyl acrylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.639; PLPHCVHEYFTFOF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -292.489; YQMRIHFIEQHCOJ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -296.544; FXIQOWGSQOLZSR; [M+CH4O+H]+; 2-Furancarboxamide, tetrahydro-N,N-dimethyl-5-oxo-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -299.669; QLTOPDVYGNULFB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -303.188; WCFJUSRQHZPVKY; [M+H]+; boc-beta-ala
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -305.197; NLSPHUUFXPUPJJ; [M+H]+; Noeurostegine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -310.785; PNOKUGWGMLEAPE; [M+CH4O+H]+; Threomycin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.876; ONLCLPRCWSOGPM; [M+H]+; 2-(3-Methyl-3-nitrobutyl)-1,3-dioxolane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -318.446; PDEQNWFUJRROAD; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.658; PEAQTUDKZGSVCV; [M+CH4O+H]+; (2S)-2-azaniumyl-2-[(1S,2S)-2-hydroxycyclopent-3-en-1-yl]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.041; VQASKUSHBVDKGU; [M+CH4O+H]+; Paradione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -327.134; PQWVIUSCFLEBHJ; [M+H]+; 2-Propenamide, N-(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)-2-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -331.155; DHDYSIHKQXBAIY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.520; ABNUGWRZSYVEEW; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -348.109; JHWZWIVZROVFEM; [M+CH4O+H]+; Leucine anhydride
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -351.550; NWPRXAIYBULIEI; [M+H]+; Methylcarbonyl-L-t-Leucine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.732; YRXIMPFOTQVOHG; [M+H]+; Boc-sarcosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -354.818; IJKKTQLUXOILBQ; [M+H]+; L-Valine, N-(2-hydroxy-1-oxopropyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.864; IRIRHXXUSZTSTF; [M+CH4O+H]+; 6-Amino-2,2-dimethyl-1,3-dioxepin-5-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -366.253; QVHJQCGUWFKTSE; [M+H]+; Boc-l-alanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.326; GNMSLDIYJOSUSW; [M+CH4O+H]+; Acetylproline
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.114; JDVVGAQPNNXQDW; [M+H]+; Tocris-0759
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -103.470; NRXANNCPNMYMJF; [M+CH4O+H]+; Ethyl (cyclopropylamino)(oxo)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.290; NWXANYGNGALYSW; [M+CH4O+H]+; 2-ethenoxy-N-[(2S)-1-oxopropan-2-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -108.374; ZVFIFXIDOPDJHZ; [M+CH4O+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -112.733; NQQHKLFBFNRBTE; [M+CH4O+H]+; (Propan-2-ylideneamino) 3-oxobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -115.645; KHZGOCSLOZQWNN; [M+CH4O+H]+; Ethyl (4,5-dihydro-1,3-oxazol-2-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.205; HUGWZLJZMADXEE; [M+CH4O+H]+; 2-Ethoxyethyl 2-isocyanoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.518; BEIBHLOZKRYRDP; [M+CH4O+H]+; 2-(Prop-2-enoxyamino)but-2-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.806; BIEMZNVEFSZYKS; [M+CH4O+H]+; n-(2,4-Dioxopentan-3-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.847; SVFFRPLYXJZDNV; [M+CH4O+H]+; (3Z,5Z)-6-(hydroxyamino)hepta-3,5-dienoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.862; KKWDXHWFNVPHLY; [M+CH4O+H]+; Ethyl 2-imino-3-oxopentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -169.699; JYGXQTZBIRNFBN; [M+H]+; 2,2'-Iminobisethyl diacetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.495; LJDNMOCAQVXVKY; [M+H]+; Diethyl iminodiacetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -216.123; AMDDRMIFTJHJGD; [M+H]+; 2-(1-Carboxyethylamino)pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -223.026; JQNOJPRGXMMBQO; [M+H]+; 2-(2-Carboxyethylamino)-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -223.927; PKTVOVWATFEUOE; [M+H]+; 2-[[Bis(2-hydroxyethyl)amino]methyl]propenoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -226.460; HMNXRLQSCJJMBT; [M+H]+; (R)-Diethyl 2-aminosuccinate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -232.949; ARUQUOQAOGPTLW; [M+H]+; Tert-butyl 2-methyl-2-nitropropionate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -240.247; DJHJARSDYMDXEN; [M+H]+; Methyl 4-methoxy-1-oxidopiperidin-1-ium-3-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -242.866; MBBNCIKYWHIZGN; [M+H]+; 1-Hydroxyhexanoylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -246.821; YOFPFYYTUIARDI; [M+H]+; 2-Amino-4-tritiooctanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.187; NRXANNCPNMYMJF; [M+CH4O+H]+; Ethyl (cyclopropylamino)(oxo)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.074; JYGXQTZBIRNFBN; [M+H]+; 2,2'-Iminobisethyl diacetate
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C8H16N1O4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 11.612
MS$FOCUSED_ION: PRECURSOR_M/Z 190.107358
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00kf-0900000000-9b1c7978410c2bb23ff0
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  70.0650805 19.7065 70.065700 0.9563 3.82 0.6853 99 f{C4H8N1}/-0.64ppm,p-C4H8O4
  86.0600333 9.3207 86.060500 2.2078 2.48 0.5201 79 f{C4H8N1O1}/-0.08ppm,p-C4H8O3
  87.0916769 270.6337 87.092130 0.3100 39.23 0.6082 99 ?
  98.0600526 134.4115 98.060390 0.4895 20.33 0.9558 99 f{C5H8N1O1}/0.13ppm,p-C3H8O3
  104.1182344 187.8884 104.118520 0.3266 30.82 0.5276 99 ?
  113.1073168 93.8015 113.107510 0.5482 17.80 0.4694 99 ?
  116.0706113 999.0000 116.070770 0.2412 123.93 0.9864 99 f{C5H10N1O2}/0.05ppm,p-C3H6O2
  130.0863020 75.1701 130.086270 0.7995 25.96 0.8058 99 f{C6H12N1O2}/0.36ppm,p-C2H4O2
  130.1339028 353.4277 130.133870 0.2997 59.04 0.4673 99 ?
  149.0233415 247.1431 149.023240 0.3422 69.23 -0.0578 99 f{C8H5O3}/0.14ppm,p-H11N1O1
  154.0862548 21.1333 154.086150 1.5186 4.72 0.8281 99 f{C8H12N1O2}/-0.00ppm,p-H4O2
  156.1495811 15.5037 156.149475 1.7163 4.02 0.4144 96 ?
  172.0967063 24.8633 172.096590 1.6619 5.24 0.8079 99 f{C8H14N1O3}/-0.66ppm,p-H2O1
  172.1642064 37.4078 172.164090 1.9981 7.10 0.6812 99 ?
  173.1284570 24.6132 173.128340 1.6288 8.66 0.6048 99 ?
  173.1760970 67.8605 173.175980 0.9008 12.66 0.4475 99 ?
  190.1074577 765.6469 190.107330 0.2946 97.33 1.0000 99 f{C8H16N1O4}/0.39ppm,p
  190.1550977 139.8486 190.154970 0.8467 44.09 0.8190 99 ?
  190.2025978 975.2463 190.202470 0.2418 159.37 0.5018 99 ?
PK$NUM_PEAK: 19
PK$PEAK: m/z int. rel.int.
  70.065080 19.71 19
  86.060033 9.32 9
  87.091677 270.63 270
  98.060053 134.41 134
  104.118234 187.89 187
  113.107317 93.80 93
  116.070611 999.00 999
  130.086302 75.17 75
  130.133903 353.43 353
  149.023342 247.14 247
  154.086255 21.13 21
  156.149581 15.50 15
  172.096706 24.86 24
  172.164206 37.41 37
  173.128457 24.61 24
  173.176097 67.86 67
  190.107458 765.65 765
  190.155098 139.85 139
  190.202598 975.25 975
//
